Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16258673rdf:typepubmed:Citationlld:pubmed
pubmed-article:16258673lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0208804lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0033375lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:16258673lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:16258673pubmed:issue3Blld:pubmed
pubmed-article:16258673pubmed:dateCreated2005-10-31lld:pubmed
pubmed-article:16258673pubmed:abstractTextPituitary carcinomas are rare neoplasms characterized by craniospinal and/or systemic metastases originated from the pituitary. Their histopathology is frequently indistinguishable from that of benign adenomas. The development of markers that better reflect their behavior is desirable. We present the case of a 47 year-old man with a prolactin-secreting macroadenoma who was submitted to surgeries, cranial radiation therapy, and bromocriptine treatment, but evolved to a fatal outcome after the disclosure of intracranial metastases. Tumor samples underwent p53 and Ki-67 immunohistochemical assessment. p53 was absent in all samples, a rare finding among pituitary carcinomas. Ki-67 proliferative index was 2.80% in the original tumor, 4.40% in the relapse, and 4.45% in the metastasis. The figure in the relapse is higher than the expected for a noninvasive adenoma. In conclusion, p53 staining is not positive in all pituitary carcinomas. A high Ki-67 proliferative index in a pituitary adenoma might indicate a more aggressive behavior.lld:pubmed
pubmed-article:16258673pubmed:languageenglld:pubmed
pubmed-article:16258673pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:citationSubsetIMlld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16258673pubmed:statusMEDLINElld:pubmed
pubmed-article:16258673pubmed:monthSeplld:pubmed
pubmed-article:16258673pubmed:issn0004-282Xlld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:SilveiraDanie...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:CrusiusPaulo...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:ForceliniCass...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:MallmannAdroa...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:LerschElderElld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:SeibertCláudi...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:CrusiusMarcel...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:CarazzoCharle...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:CrusiusCassia...lld:pubmed
pubmed-article:16258673pubmed:authorpubmed-author:GoellnerEduar...lld:pubmed
pubmed-article:16258673pubmed:issnTypePrintlld:pubmed
pubmed-article:16258673pubmed:volume63lld:pubmed
pubmed-article:16258673pubmed:ownerNLMlld:pubmed
pubmed-article:16258673pubmed:authorsCompleteYlld:pubmed
pubmed-article:16258673pubmed:pagination864-9lld:pubmed
pubmed-article:16258673pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:meshHeadingpubmed-meshheading:16258673...lld:pubmed
pubmed-article:16258673pubmed:year2005lld:pubmed
pubmed-article:16258673pubmed:articleTitleMetastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens.lld:pubmed
pubmed-article:16258673pubmed:affiliationInstitute of Neurology and Neurosurgery, Passo Fundo, RS, Brazil.lld:pubmed
pubmed-article:16258673pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16258673pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16258673lld:pubmed